A Dose-escalation Study of AND017 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

February 11, 2019

Study Completion Date

February 11, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

AND017 single dose

AND017 administrated as oral single-dose on Day 1 in Part A

DRUG

AND017 multiple dose

AND017 administrated once daily from Day 1 to Day 10 in Part B

DRUG

Placebo

Placebo administrated once on Day 1 in Part A or daily from Day 1 to Day 10 in Part B

Trial Locations (1)

2031

Scientia Clinical Research, Randwick

Sponsors
All Listed Sponsors
lead

Kind Pharmaceuticals LLC

INDUSTRY